BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld
Home
» Other news to note for Jan. 12, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Jan. 12, 2022
Jan. 12, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 2Seventy, Affibody, Amicus, Beyondspring, Bharat Biotech, Bristol Myers Squibb, Curateq, Heat
,
Iaso, Immix, Immuron, Innovent, Kintara, Lantern, Lokon, Merck, Mynd Life Sciences, Neogene, Neurocrine, Neurorx, Nuravax, Ocugen, Orion, Panavance, Plus, Relief, Revelation, Sana, Targovax, Xenon, Yumanity.
BioWorld
Briefs
Other news to note
Coronavirus